Viewing Study NCT02879994


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-31 @ 7:44 PM
Study NCT ID: NCT02879994
Status: COMPLETED
Last Update Posted: 2021-07-14
First Post: 2016-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization: